Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cells and type 1 innate lymphoid cells in cancer
Noëlla Lopes, Éric Vivier, Émilie Narni-Mancinelli
Seminars in Immunology (2023) Vol. 66, pp. 101709-101709
Open Access | Times Cited: 24

Showing 24 citing articles:

Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Diversity of group 1 innate lymphoid cells in human tissues
Natália Jaeger, Alina Ulezko Antonova, Daniel Kreisel, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1460-1473
Closed Access | Times Cited: 7
Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation
Raki Sudan, Susan Gilfillan, Marco Colonna
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 107-117
Closed Access | Times Cited: 5
Ovarian cancer treatment and natural killer cell-based immunotherapy
Zhongru Fan, Dongyu Han, Xin Fan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
Rimma Laufer Britva, Aviad Keren, Marta Bertolini, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 10
Global research trends on innate lymphoid cells in the brain, gut and lung field: a bibliometric and visualized analysis
Jianliang Huang, Kun Deng, Ying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function
Siyu Wang, Yuxin Wang, Ao Shen, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer
Ming O. Li, Jing Zhang, Zijian Xu, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 647-677
Closed Access | Times Cited: 2
Relationship between tumorigenesis, metastasis, immune evasion, and chemoresistance in osteosarcoma therapy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Mainul Haque, et al.
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 5
Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment
Rossella Paolini, Rosa Molfetta
Cancers (2023) Vol. 15, Iss. 18, pp. 4616-4616
Open Access | Times Cited: 5
Inflammation and Cancer: A Temporal Perspective on Emerging Cellular and Molecular Mechanisms, Focusing on Gastrointestinal Cancers
Hikmet Akkız, Halis Şinşek, Deniz Balcı, et al.
(2024)
Open Access | Times Cited: 1
Relationship between Osteosarcoma Therapy and Tumorigenesis, Metastasis, Immune Evasion, and Chemoresistance
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Mainul Haque, et al.
(2023)
Open Access | Times Cited: 2
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
Nathalie Bendriss‐Vermare, Valentin Picant, Lara Revol-Bauz, et al.
Research Square (Research Square) (2024)
Open Access
Implications of innate lymphoid cells in oral diseases
Si-Ting Hu, Gang Zhou, Jing Zhang
International Immunopharmacology (2024) Vol. 133, pp. 112122-112122
Closed Access
The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Yongjing Shi, Xiaodong Zheng, Hui Peng, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 10, pp. 1438-1451
Closed Access
Natural Killer Cell Cellular-based Therapeutic Options to Manage Acute Myeloid Leukemia: Prospects and Challenges
Ogochukwu Izuegbuna
Deleted Journal (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer
Shreya Chowdhury, Katherine Murphy, Chaitanya N. Parikh, et al.
Methods in cell biology (2024), pp. 171-201
Closed Access
Innate lymphoid cells in the brain: Focus on ischemic stroke
Khiany Mathias, Richard Simon Machado, Taise Cardoso, et al.
Microvascular Research (2024) Vol. 157, pp. 104755-104755
Closed Access
Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells
Ali Hazrati, Seyed Mohamad Javad Mirarefin, Kosar Malekpour, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
In vitro ILC differentiation from human HSCs
Silvia Santopolo, Cecilia Ciancaglini, Francesca Romana Mariotti, et al.
Methods in cell biology (2024), pp. 41-57
Closed Access
Functional and phenotypic changes in natural killer cells expressing immune checkpoint receptors PD-1, CTLA-4, LAG-3, and TIGIT in non-small cell lung cancer: the comparative analysis of tumor microenvironment, peripheral venous blood, and tumor-draining veins
Fehim Esen, Duygu İlke Çıkman, Ayşe Engin, et al.
Immunologic Research (2024) Vol. 73, Iss. 1
Closed Access
Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers
Hobin Seo, Amisha Verma, Megan Kinzel, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 2001-2001
Open Access | Times Cited: 1
Innate immune effectors in cancer
Lorenzo Moretta, Paola Vacca
Seminars in Immunology (2023) Vol. 67, pp. 101760-101760
Open Access
Natural Killer Cell Cellular–Based Therapeutic Options for Management of Acute Myeloid Leukemia: Prospect and Challenges
Ogochukwu Izuegbuna
(2023)
Open Access
Page 1

Scroll to top